Lara Kay

684 total citations
15 papers, 333 citations indexed

About

Lara Kay is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lara Kay has authored 15 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 14 papers in Psychiatry and Mental health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lara Kay's work include Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (5 papers). Lara Kay is often cited by papers focused on Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (5 papers). Lara Kay collaborates with scholars based in Germany, Switzerland and Canada. Lara Kay's co-authors include Felix Rosenow, Adam Strzelczyk, Laurent M. Willems, Susanne Knake, Susanne Schubert‐Bast, Philipp S. Reif, Sebastian Bauer, Anke Hermsen, Karl Martin Klein and Johann Philipp Zöllner and has published in prestigious journals such as Epilepsia, Journal of Neurology and CNS Drugs.

In The Last Decade

Lara Kay

15 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara Kay Germany 10 281 229 141 29 16 15 333
Monica S. Cooper Australia 8 334 1.2× 217 0.9× 75 0.5× 27 0.9× 17 1.1× 21 427
Timothy Martland United Kingdom 8 242 0.9× 196 0.9× 50 0.4× 29 1.0× 10 0.6× 16 295
Ulrich Specht Germany 11 372 1.3× 295 1.3× 71 0.5× 23 0.8× 16 1.0× 26 426
Gregory S. Carter United States 5 337 1.2× 308 1.3× 109 0.8× 28 1.0× 30 1.9× 9 405
Colin Kazina Canada 11 157 0.6× 90 0.4× 88 0.6× 19 0.7× 6 0.4× 23 261
Hamdy N. El-Tallawy Egypt 11 188 0.7× 140 0.6× 34 0.2× 15 0.5× 19 1.2× 24 358
Thomas E. Beniak United States 7 259 0.9× 182 0.8× 85 0.6× 78 2.7× 12 0.8× 9 316
Claudia A. Granbichler Austria 12 514 1.8× 379 1.7× 202 1.4× 78 2.7× 64 4.0× 15 601
Simon Borghs United Kingdom 14 592 2.1× 529 2.3× 270 1.9× 39 1.3× 29 1.8× 39 660
Justin Martello United States 7 289 1.0× 166 0.7× 90 0.6× 59 2.0× 16 1.0× 13 466

Countries citing papers authored by Lara Kay

Since Specialization
Citations

This map shows the geographic impact of Lara Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Kay more than expected).

Fields of papers citing papers by Lara Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Kay. The network helps show where Lara Kay may publish in the future.

Co-authorship network of co-authors of Lara Kay

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Kay. A scholar is included among the top collaborators of Lara Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Kay. Lara Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kienitz, Ricardo, Lara Kay, Isabelle Beuchat, et al.. (2022). Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability. CNS Drugs. 36(9). 951–975. 69 indexed citations
2.
Schubert‐Bast, Susanne, et al.. (2021). Epidemiology, healthcare resource use, and mortality in patients with probable Dravet syndrome: A population-based study on German health insurance data. Epilepsy & Behavior. 126. 108442–108442. 10 indexed citations
3.
Kay, Lara, Leona Möller, Philipp S. Reif, et al.. (2020). Prone, lateral, or supine positioning at seizure onset determines the postictal body position: A multicenter video-EEG monitoring cohort study. Seizure. 76. 173–178. 11 indexed citations
4.
Zöllner, Johann Philipp, Susanne Knake, Yulia Oganian, et al.. (2020). Risk incidence of fractures and injuries: a multicenter video-EEG study of 626 generalized convulsive seizures. Journal of Neurology. 267(12). 3632–3642. 18 indexed citations
5.
Kay, Lara, Susanne Knake, Johann Philipp Zöllner, et al.. (2020). Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring. CNS Drugs. 34(5). 545–553. 23 indexed citations
6.
Kay, Lara, Sebastian Bauer, Felix Rosenow, Adam Strzelczyk, & Johann Philipp Zöllner. (2019). Medikamentöse Therapie von epileptischen Anfällen und Epilepsien. Nervenheilkunde. 38(12). 887–901. 1 indexed citations
7.
Kay, Lara, Laurent M. Willems, Sebastian Bauer, et al.. (2019). Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study. Annals of Clinical and Translational Neurology. 6(12). 2413–2425. 25 indexed citations
8.
Bauer, Sebastian, Anke Hermsen, Ilka Immisch, et al.. (2018). Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany. CNS Drugs. 32(8). 771–781. 29 indexed citations
9.
Willems, Laurent M., Lara Kay, Anke Hermsen, et al.. (2018). Incidence, Risk Factors and Consequences of Epilepsy-Related Injuries and Accidents: A Retrospective, Single Center Study. Frontiers in Neurology. 9. 414–414. 49 indexed citations
10.
Strzelczyk, Adam, Lara Kay, Sebastian Bauer, et al.. (2018). Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus. Epilepsia. 59(8). 1549–1556. 55 indexed citations
11.
Willems, Laurent M., Lara Kay, Felix Rosenow, & Adam Strzelczyk. (2018). Krankheitskosten und Outcome: Versorgungsrealität des Status epilepticus. Zeitschrift für Epileptologie. 31(4). 267–271. 4 indexed citations
12.
Strzelczyk, Adam, Lara Kay, Christoph Kellinghaus, et al.. (2017). Concepts for Prehospital and Initial In-hospital Therapy of Status Epilepticus. 1(3). E217–E223. 4 indexed citations
13.
Kay, Lara, Laurent M. Willems, Johann Philipp Zöllner, et al.. (2017). Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01. Seizure. 47. 81–82. 7 indexed citations
14.
Strzelczyk, Adam, Lara Kay, Christoph Kellinghaus, et al.. (2017). Konzepte zur prähospitalen und initialen intrahospitalen Therapie des Status epilepticus. Aktuelle Neurologie. 44(9). 637–644. 1 indexed citations
15.
Kay, Lara, Philipp S. Reif, Marcus Belke, et al.. (2015). Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic–clonic seizures. Epilepsia. 56(9). 1408–1414. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026